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INTRODUCTION
In recent years, several innate lymphoid cell (ILC) populations have been described. Characterized by the absence of rearranged antigen-specific receptors, these cells have been classified into group 1, 2, and 3 ILCs, with each group mirroring a respective T helper cell population (Fuchs et al., 2013; Klose et al., 2014; Robinette et al., 2015) . Group 1 ILCs comprise natural killer (NK) cells and ILC1 that are defined by a dependence on the Eomes or T-bet transcription factors, respectively. These cells have the capacity to respond to interleukin (IL)-12, IL-15, and IL-18 to produce interferon (IFN)-g (Fuchs et al., 2013; Klose et al., 2014) . Group 2 ILCs are defined by a dependence on the transcription factors RORa and GATA-3 and the capacity to respond to IL-33, IL-25, and thymic stromal lymphopoietin to produce type 2 cytokines, such as IL-5 and IL-13. Lastly, group 3 ILCs are defined by a dependence on RORgt and the capacity to respond to IL-1b and IL-23 by the production of IL-22, IL-17A, and/or IL-17F (Fuchs et al., 2013; Klose et al., 2014; Robinette et al., 2015; Tait Wojno and Artis, 2012) .
Abundant at mucosal barrier surfaces (Klose et al., 2014; Robinette et al., 2015) , ILCs have been assigned important roles in a number of immunological processes. Whereas ILC1s have been implicated in the control of intracellular parasite infections (Klose et al., 2014; Schulthess et al., 2012) and gut inflammation (Bernink et al., 2013b; Fuchs et al., 2013) , ILC2s are important in the clearance of helminth (Neill et al., 2010 ) and viral infections and in the progression of asthma and lung allergies (Chang et al., 2011; Mjö sberg et al., 2011; Nussbaum et al., 2013; Spits and Cupedo, 2012; Klein Wolterink et al., 2012) . ILC3s, in turn, contribute to tertiary lymphoid organogenesis (van de Pavert and Mebius, 2010) , the containment of commensal bacteria (Sonnenberg and Artis, 2012) , and clearance of bacterial infections in the gut (Cella et al., 2009; Diefenbach, 2013; Klose et al., 2013; Satoh-Takayama et al., 2008; Sonnenberg et al., 2011) , and they have been implicated in the pathology of inflammatory bowel disease (Bernink et al., 2013b; Buonocore et al., 2010; Geremia et al., 2011) . It should be noted that some of the described functions are attributable to ex-RORgt + ILC3s (Bernink et al., 2013b; Vonarbourg et al., 2010) , where bidirectional functional plasticity between ILC1 and ILC3 classes in response to distinct environmental stimuli was recently demonstrated (Bernink et al., 2015) . Whereas group 2 ILCs appear to be the most homogeneous cells, considerable heterogeneity exists within group 1 and 3 ILCs. In the gut, a distinction can be made within group 1 ILCs among conventional natural killer (cNK) cells, lamina propria (Klose et al., 2014) and intraepithelial ILC1s (Fuchs et al., 2013) , and ex-RORgt + ILC3s (Bernink et al., 2013b; Vonarbourg et al., 2010) . The cNK cells are considered to be CD27 + CD127(IL-7Ra) À NKp46 + NK1.1 + cells that express both Eomes and T-bet. Whereas cNK cells are dramatically reduced in Eomes F/F 3 Vav-Cre mice (Gordon et al., 2012) , they are only slightly reduced in Tbx21 À/À mice (Klose et al., 2014; Townsend et al., 2004) . NK cells are cytotoxic in nature, and they may also be stimulated to produce the signature cytokine IFN-g. Intraepithelial ILC1 (Fuchs et al., 2013) and lamina propria ILC1 (Klose et al., 2014 ) have a CD27 + CD127 + NKp46 + NK1.1 + phenotype. Intraepithelial ILC1s, similar to NK cells, express both Eomes and T-bet. However, in contrast to cNK cells, intraepithelial ILC1s are largely independent of IL-15Ra (Fuchs et al., 2013) . Lamina propria ILC1s express T-bet, but not Eomes, rely on IL-15 for their maintenance/survival, and express IFN-g upon stimulation (Klose et al., 2014 (Robinette et al., 2015) . Recently, CD8aa + innate-type lymphocyte (iCD8a) cells, an innate lymphoid population resident to the intestinal epithelium, were also described (Van Kaer et al., 2014) . Ly49E, a member of the Ly49 NK receptor family, is preferentially expressed on innate lymphocytes. In this respect, the Ly49E receptor is expressed on innate-like epidermal Vg3 T cells as well as intestinal CD8aa + intraepithelial T lymphocytes (Taveirne et al., 2011; Van Acker et al., 2014; Van Beneden et al., 2002) . Alongside, Ly49E expression is low on cNK cells from adult mice (Van Beneden et al., 2001 ), but it is highly expressed on CD49a + liver NK cells (Filtjens et al., 2013) . Interestingly, the latter have recently been shown to have ILC1-like properties (Robinette et al., 2015; Tang et al., 2016) . As such, we investigated whether Ly49E is expressed on intestinal ILC populations. In this paper we show that, whereas Ly49E expression is low on conventional ILC1 and ILC3 populations, Ly49E defines a previously unrecognized NKp46-negative intraepithelial lymphocyte (IEL) population that can be minimally characterized as NKp46 À CD8aa À Ly49E + . This intestinal IEL population requires IL-15-mediated, but not IL-7-mediated, signaling for maintenance; is dependent on T-bet, but not on Eomes or RORgt; and has a gene expression profile that is closely related to both lamina propria ILC1 and NK cells. Importantly, in vitro stimulation with IL-12, IL-15, and IL-18, or in vivo Toxoplasma gondii infection, induces IFN-g expression by these cells, confirming the ILC1-like nature and the capacity to contribute to Th1-mediated immune responses.
RESULTS

Ly49E
Is Primarily Expressed on NKp46-Negative Intestinal IEL We have previously shown that the Ly49E receptor is expressed on several innate-like cell populations in adult C57BL/6 mice (Filtjens et al., 2013; Taveirne et al., 2011; Van Acker et al., 2014; Van Beneden et al., 2002) . Recent years have seen the discovery of a number of innate lymphoid populations, i.e., the ILCs, with particular diversity of these cells in the small intestine (Robinette et al., 2015) . Klose et al. (2014) Figure 2B ), suggestive of a tissue-resident intraepithelial ILC phenotype (Fuchs et al., 2013; Robinette et al., 2015) . A fraction of cells from both populations expressed CD49b but at lower levels compared to NK cells. Furthermore, both populations were CD127 (Bernink et al., 2013b (Bernink et al., , 2015 Previous studies have shown that ILCs require signaling through the common gamma chain (gc) for their survival (Bernink et al., 2013a (Bernink et al., , 2013b Satoh-Takayama et al., 2010 Figure 6D ). Finally, comparative analysis of the expression levels of genes of the recently described NK cell-distinct ILC core signature (Robinette et al., 2015) showed that these genes were expressed Figure 6E , upper panel), whereas the majority of NK-specific signature genes were only expressed at low levels ( Figure 6E , lower panel). Figure S1 ). Intestinal NKp46 + IELs were transferred as a control. As expected, these cells were stable upon transfer, with a minor fraction of cells expressing Ly49E, similar to the starting donor population ( Figure S1 ). Figure 3 ) and express Prf1, Gzma, and Gzmb mRNA ( Figure 6D ). Intracellular flow cytometric analysis confirmed perforin, granzyme A, and granzyme B expression at the protein level ( Figure 7A ), indicating that these cell populations may have cytotoxic potential. We therefore sorted these cells to high purity and tested their capacity to kill NK-sen- Figure 7C ). With respect to the function of the Ly49E receptor in the immune system, our group has conclusively demonstrated that Ly49E is an inhibitory receptor in NK cells, restricting NK cell cytotoxicity and cytokine production upon interaction with its ligand uPA (Van Den Broeck et al., 2008) . We therefore also stimulated the cells with IL-12 + IL-15 + IL-18 in the presence of uPA or BSA as a negative control. The presence of uPA did not alter IFN-g production of cytokine-stimulated CD8aa À Ly49E + or CD8aa + Ly49E + IELs ( Figure 7D ). , IELs contribute in immunity to T. gondii infection through production of IFN-g (Figure 7E) . As a control, we confirmed that IFN-g was produced by lamina propria ILC1s upon T. gondii infection (data not shown), as previously described by Klose et al. (2014) .
DISCUSSION
The intestinal epithelium harbors a number of lymphocyte populations, including innate-like and adaptive T cells, NKp46-expressing NK cells and ILC1s, and the recently described iCD8a cells (Fuchs et al., 2013; Van Kaer et al., 2014) . In this paper, we show that the intestinal epithelium is also home to a previously unrecognized CD3 À innate population that can be minimally characterized as NKp46 À CD8aa À Ly49E + . Further study of these cells revealed a lymphoid morphology and a (Robinette et al., 2015) . CD8aa
À
Ly49E
+ IELs did not express cell surface CD127. However, microarray analysis revealed large numbers of Il7r transcripts, suggesting that Il7r expression may not, or not sufficiently, be translated onto the protein level in these cells to allow flow cytometric detection.
Alternatively, CD8aa
À Ly49E + IELs may reside in an IL-7 hi environment and downregulate CD127. As intraepithelial ILC1 and iCD8a cells have also been shown to lack detectable surface expression of CD127 (Fuchs et al., 2013; Van Kaer et al., 2014) , it is worthwhile to consider that absence of CD127 on the surface membrane of these three cell populations may be a feature of their intraepithelial localization, whereas ILCs located in the lamina propria are CD127 + (Klose et al., 2014 ).
This notion is further corroborated by data from human studies, which have also described the existence of intraepithelial are not NK cells. Comparing our data with the recently described NK cell-distinct core signature, i.e., a set of transcripts common to ILC1 from all tissues that are more highly expressed than in NK cell subsets and that also show high expression in ILC2 and ILC3 subsets (Robinette et al., 2015) , CD8aa phenotype and express CD49a, a marker present on tissue-resident ILC1s and absent on NK cells (Klose et al., 2014; Robinette et al., 2015) . In addition, these cells do not express the typical NK receptor NKG2D, and, most importantly, CD8aa There are also important differences between the intestinal CD8aa À Ly49E + IELs described in the present paper and the previously described intestinal intraepithelial and lamina propria ILC1s. In contrast to CD8aa
À
Ly49E
+ IELs, murine intestinal intraepithelial ILC1s have an NKp46 + NK1.1 + phenotype and are negative for CD103. In addition, intraepithelial ILC1s are largely independent of IL-15Ra (Fuchs et al., 2013) A role for both intraepithelial and lamina propria ILC1s in mediating Th1-type immune response has been demonstrated (Fuchs et al., 2013; Klose et al., 2014 
.1 À phenotype, as also described for iCD8a cells (Van Kaer et al., 2014) . Furthermore, we showed that these cells express CD49a, suggesting a tissue-resident ILC1-like phenotype (Fuchs et al., 2013; Klose et al., 2014; Robinette et al., 2015) . CD8aa + Ly49E + IELs had a lymphoid morphology and were granular, in accordance with high expression of Grzma and Grzmb of iCD8a cells (Van Kaer et al., 2014 IELs also had higher gene expression of Ccr9, Ifng, Tnf, Il2ra, Il7r, Il18r, Il1r1, Podnl1, Tmem176a, and Tmem176b . Conclusively, we have defined an intestinal intraepithelial ILC1-like population that is distinct from the previously described NKp46 + NK1.1 + CD160 + intraepithelial ILC1 population (Fuchs et al., 2013) , the NKp46 + NK1.1 + CD127 + lamina propria ILC1 population (Klose et al., 2014) , and also distinct from NK cells. Of note, a recent paper also describes the existence of a population of salivary gland group 1 ILCs distinct from both NK and ILC1s, thus highlighting the heterogeneity of group 1 ILCs at multiple mucosal sites (Cortez et al., 2016) . Moreover, a contemporary paper describes the presence of non-circulating innate-like T cell receptor ab and gd lymphocytes, in addition to ILC1-like cells, in mammary tissue (Dadi et al., 2016 T-Cre) (Arnold et al., 2008; Perantoni et al., 2005) , Tbx21 À/À (Szabo et al., 2002) , Rorc(gt) Gfp/Gfp , Il7ra À/À (Peschon et al., 1994) , Il15ra À/À (Kennedy et al., 2000) , and RORgt-fm (Rorc(gt)-Cre Tg 3
Rosa26R
Yfp/+ ) mice were on a C57BL/6 background. Both females and males were used at the age of 2-6 months. All animal experimentation was performed after approval and according to the guidelines of the Ethical Committee for Experimental Animals at the Faculty of Medicine and Health Sciences of Ghent University, the Landesuntersuchungsamt Koblenz, and the Landesverwaltungsamt Sachsen-Anhalt.
Intestinal IEL and Lamina Propria Lymphocyte Isolation IELs were isolated from the small intestine as described previously (Van Acker et al., 2014 ) (see the Supplemental Experimental Procedures). Briefly, small intestinal fragments were mechanically digested in a Ca/Mg-free buffer, and IELs were enriched by density gradient centrifugation. Thereafter, the small intestinal fragments were dispase/collagenase treated, and lamina propria lymphocytes (LPLs) were isolated by density gradient centrifugation (see the Supplemental Experimental Procedures).
Immunofluorescence Staining and Antibodies
Following isolation, cells were labeled with antibodies for flow cytometric analysis (see the Supplemental Experimental Procedures). Flow cytometry was performed using a BD LSRII flow cytometer, and samples were analyzed with FACSDiva Version 6. 
CD8aa
+ Ly49E À IELs of NOD-SCID mice were sorted to high purity (>98%) in three independent experiments using a BD FACSAria III cell sorter (BD Biosciences). Transcriptome analysis was performed using the Affymetrix Mouse Gene 1.0ST Array (Affymetrix) (see the Supplemental Experimental Procedures).
In Vitro Cell Stimulation
Intestinal IELs were isolated from NOD-SCID mice and cultured in complete RPMI medium in the presence of IL-12 (20 ng/mL; R&D Systems), and/or IL-15 (10 ng/mL; R&D Systems), and/or IL-18 (2.5 ng/mL; Medical and Biological Laboratories) for 15 hr. Alternatively, wells were precoated with uPA (Molecular Innovations) or BSA at 200 ng/mL for 6 hr, before the different cell populations were cultured in the presence of different cytokine combinations for an additional 15 hr. In both experimental conditions, Brefeldin A (Golgistop, BD Biosciences) (1 mg/mL) was added during the last 12 hr. Cells were harvested and stained as described. Cr-release assay, as previously described (Filtjens et al., 2013) . Percentage specific lysis was calculated as 100 3 ([experimental release À spontaneous release]/[total release À spontaneous release]).
Cytotoxicity Assay
T. gondii Infection T. gondii cysts of type II strain ME 49 were harvested from the brains of female NMRI mice infected intraperitoneally with T. gondii cysts 8-10 months earlier. Brains obtained from infected mice were mechanically homogenized in 1 mL sterile PBS, and the cysts were counted using a light microscope. NOD-SCID mice were infected by oral gavage with ten T. gondii cysts.
Statistical Analysis
Statistical analysis was carried out using PASW Statistics 22 Software (SPSS) or GraphPad Prism5 Software. Data were analyzed using the non-parametric two-tailed Mann-Whitney U test. A p value % 0.05 was considered statistically significant.
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